Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Effect of Low-dose Isotretinoin on Proliferative Vitreoretinopathy

NCT01445028 is registered in ClinicalTrials.gov with Wills Eye as lead sponsor.

NCT NCT01445028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01445028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Effect of Low-dose Isotretinoin on Proliferative Vitreoretinopathy
Lead sponsor
Wills Eye
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2011
Completion date
August 31, 2015
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative vitreoretinopathy